Banca de DEFESA: GABRIEL PEREIRA DUARTE

RESPIRATORY FUNCTION OF ELDERLY WITH THE DISEASE OF PARKINSON SUBMITTED TO TRAINING FUNCTIONAL,

 STATIONARY BICYCLE AND EXERGAME: A UNICEGO RANDOMIZED CLINICAL TRIAL

Parkinson disease, Respiratory Function Tests, Physical Therapy Modalities, Aged.

although respiratory function (RF) is diminished in the early stages of Parkinson's disease (PD), conventional and alternative physical therapy interventions don’t focus impaired respiratory function. OBJECTIVE: the aim of the study was to evaluate the effects of functional training, training on a stationary bicycle, and exercises performed on Exergame, on the respiratory function of elderly people with Parkinson’s disease in mild and moderate stages. METHODS: a total of 58 participants completed the intervention protocol, randomized into 3 groups, 18 in the functional training group (FG), 20 in the stationary bicycle training group (GB) and 18 in the Exergame group (GE). All interventions had a duration of 8 weeks and a frequency of 3 times a week. As a primary endpoint, forced expiratory volume in the first second (FEV1) was investigated. Secondary end points were forced vital capacity (FVC), peak expiratory flow (PEF), maximum inspiratory pressure (Pimax), and maximum expiratory pressure (Pemax). The evaluations were carried out before and after the interventions by a single blinded researcher. RESULTS: the performed interventions did not present significant results on FVC, FEV1 and PEF. However, GB showed a significant improvement in Pemax, median from 60cmH2o to 80cmH20 (p = 0.03) and the EG significantly improved Pimax, median from -58cmH2o to -70cmH2o (p = 0.01). There was no difference in the comparison between the groups. CONCLUSION: The interventions performed did not significantly change FVC, FEV1 and PEF however aerobic training on a stationary bicycle improved expiratory muscle strength and exergame exercises improved inspiratory muscle strength. These results suggest the need to evaluate and implement actions to prevent and treat respiratory function decline in elderly people with Parkinson’s disease at an early stage.